Delays in treating a patient with an aggressive form of prostate cancer more than likely contributed to his disease advancing ...

An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical ...

Read more about the factors that patients with prostate cancer value most in treatment decisions, as reported at EAU 2026.

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...

As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...

Pfizer Inc. PFE shares are up during Thursday’s trading session after the company shared data from Talzenna plus Xtandi’s investigational treatment regimen for HRR gene-mutated metastatic ...

Pfizer Inc. (NYSE:PFE) announced that its Phase 3 TALAPRO-3 clinical trial met its primary endpoint, demonstrating that the combination of TALZENNA (talazoparib) and XTANDI (enzalutamide) ...

Days after Zohran Mamdani won the Democratic mayoral primary in a major upset, Democrats nationally and in New York are still deciding whether to give him their full support. “We have moved from the ...